Research advances in hemorrhage after endoscopic retrograde cholangiopancreatography

Ling FAN; Yan FU; Yi LIU; Hua HUANG; Jing NI; Juan TANG

doi:10.3969/j.issn.1001-5256.2023.10.032

Volume 39 Issue 10

Oct. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(10): 2497-2505

PDF( 731 KB)

Research advances in hemorrhage after endoscopic retrograde cholangiopancreatography

DOI: 10.3969/j.issn.1001-5256.2023.10.032

Department of Gastroenterology，The Second Affiliated Hospital of Kunming Medical University，Kunming 650101，China

Research funding:

Yunnan Province Special Project for Famous Medical Talents (YNWR－MY－2019－074);

Postgraduate Innovation Fund of Kunming Medical University (2022S270)

More Information

Corresponding author: FU Yan， ky_fuyan@163.com （ORCID： 0000－0001－6955－0199）
Received Date: 2023-01-10
Published Date: 2023-10-30

Abstract

Abstract

Although hemorrhage after endoscopic retrograde cholangiopancreatography （ERCP） is mostly mild and self－limited， sometimes blood transfusion and endoscopic hemostasis are still needed. However， rebleeding may occur after conventional endoscopic hemostasis and thus requires interventional vascular embolization or surgical intervention， which might significantly increase the risk of death associated with post－ERCP bleeding. This article discusses the risk factors for post－ERCP bleeding， including disease－specific factors， patient－related factors， and operation－related factors， and elaborates on different measures for the prevention and treatment of post－ERCP bleeding， so as to provide a reference for identifying the high－risk population for bleeding and developing precise surgical strategies in clinical practice.
- Cholangiopancreatography， Endoscopic Retrograde,
- Postoperative Hemorrhage,
- Therapeutics,
- Risk Factors

FullText(HTML)

References(69)

References

[1]	group ERCP, Chinese Society of Digestive Endoscopology; group Biliopancreatic, Chinese Association of Gastroenterologist and Hepatologist; National Clinical Research Center for Digestive Diseases. Chinese guidelines for ERCP(2018)[J]. J Clin Hepatol, 2018, 34( 12): 2537－ 2554. DOI: 10.3969/j.issn.1001－5256.2018.12.009. 中华医学会消化内镜学分会ERCP学组, 中国医师协会消化医师分会胆胰学组, 国家消化系统疾病临床医学研究中心. 中国经内镜逆行胰胆管造影术指南(2018版)[J]. 临床肝胆病杂志, 2018, 34( 12): 2537－ 2554. DOI: 10.3969/j.issn.1001－5256.2018.12.009.
[2]	DUMONCEAU JM, KAPRAL C, AABAKKEN L, et al. ERCP－related adverse events: European Society of Gastrointestinal Endoscopy(ESGE) guideline[J]. Endoscopy, 2020, 52( 2): 127－ 149. DOI: 10.1055/a－1075－4080.
[3]	AK Ç, AYKUT H, PALA EM, et al. Post－ERCP complication analysis of an experienced center[J]. Surg Laparosc Endosc Percutan Tech, 2022, 32( 6): 707－ 713. DOI: 10.1097/SLE.0000000000001113.
[4]	ASGE Standards of Practice Committee, CHANDRASEKHARA V, KHASHAB MA, et al. Adverse events associated with ERCP[J]. Gastrointest Endosc, 2017, 85( 1): 32－ 47. DOI: 10.1016/j.gie.2016.06.051.
[5]	MALEUX G, BIELEN J, LAENEN A, et al. Embolization of post－biliary sphincterotomy bleeding refractory to medical and endoscopic therapy: Technical results, clinical efficacy and predictors of outcome[J]. Eur Radiol, 2014, 24( 11): 2779－ 2786. DOI: 10.1007/s00330－014－3332－5.
[6]	LIANG YX, NONG B, YE HL, et al. Treatment strategy of rare hemorrhage related to endoscopic retrograde cholangiopancreatography[J]. J Minim Invasive Med, 2017, 12( 4): 486－ 488. DOI: 10.11864/j.issn.1673.2017.04.11. 梁运啸, 农兵, 叶会兰, 等. 内镜逆行胰胆管造影术相关罕见出血的治疗策略[J]. 微创医学, 2017, 12( 4): 486－ 488. DOI: 10.11864/j.issn.1673.2017.04.11.
[7]	COTTON PB, LEHMAN G, VENNES J, et al. Endoscopic sphincterotomy complications and their management: An attempt at consensus[J]. Gastrointest Endosc, 1991, 37( 3): 383－ 393. DOI: 10.1016/S0016－5107(91)70740－2.
[8]	KUNDUMADAM S, PHATHARACHARUKUL P, REINHART K, et al. Bleeding after elective interventional endoscopic procedures in a large cohort of patients with cirrhosis[J]. Clin Transl Gastroenterol, 2020, 11( 12): e00288. DOI: 10.14309/ctg.0000000000000288.
[9]	KIM JY, LEE HS, CHUNG MJ, et al. Bleeding complications and clinical safety of endoscopic retrograde cholangiopancreatography in patients with liver cirrhosis[J]. Yonsei Med J, 2019, 60( 5): 440－ 445. DOI: 10.3349/ymj.2019.60.5.440.
[10]	LI JL, HU JX, LI P, et al. Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: A multicenter, retrospective, clinical study[J]. Chin Med J(Engl), 2022, 135( 19): 2319－ 2325. DOI: 10.1097/CM9.0000000000002248.
[11]	NAVANEETHAN U, NJEI B, ZHU X, et al. Safety of ERCP in patients with liver cirrhosis: A national database study[J]. Endosc Int Open, 2017, 5( 4): E303－E314. DOI: 10.1055/s－0043－102492.
[12]	NAKAJI S, OKAWA Y, NAKAMURA K, et al. Predictive model of bleeding following endoscopic sphincterotomy for the treatment of choledocholithiasis in hemodialysis patients: A retrospective multicenter study[J]. JGH Open, 2020, 4( 5): 915－ 922. DOI: 10.1002/jgh3.12363.
[13]	TSAI MC, WANG CC, WANG YT, et al. Major bleeding risk of endoscopic sphincterotomy versus endoscopic papillary balloon dilatation in hemodialysis patients[J]. Saudi J Gastroenterol, 2019, 25( 2): 106－ 112. DOI: 10.4103/sjg.SJG_246_18.
[14]	NAKAJI S, HIRATA N, MATSUI H, et al. Hemodialysis is a strong risk factor for post－endoscopic sphincterotomy bleeding in patients with choledocholithiasis[J]. Endosc Int Open, 2018, 6( 5): E568－E574. DOI: 10.1055/a－0587－4470.
[15]	HE W, MU QM, WANG G, et al. Analysis of risk factors for bleeding in patients with malignant obstructive jaundice after endoscopic retrograde cholangiopancreatography[J]. Int J Surg, 2022, 49( 1): 10－ 15, F 3. DOI: 10.3760/cma.j.cn115396－20210924－00378. 贺伟, 母齐鸣, 王刚, 等. 恶性梗阻性黄疸患者经ERCP后出血的危险因素分析及模型预测[J]. 国际外科学杂志, 2022, 49( 1): 10－ 15, F 3. DOI: 10.3760/cma.j.cn115396－20210924－00378.
[16]	TANG YH. Analysis of high risk factors and countermeasures of bleeding after endoscopic retrograde cholangiopancreatography[J]. Lab Med Clin, 2021, 18( 16): 2414－ 2417. DOI: 10.3969/j.issn.1672－9455.2021.16.032. 唐亚红. 内镜逆行胰胆管造影术后出血的高危因素及对策分析[J]. 检验医学与临床, 2021, 18( 16): 2414－ 2417. DOI: 10.3969/j.issn.1672－9455.2021.16.032.
[17]	LI YN, XUE JH. Factors analysis and nursing measures of biliary bleeding after endoscopic retrograde cholangiopancreatography[J]. Chin J Thromb Hemostasis, 2022, 28( 1): 131－ 133. 李英妮, 薛军花. 内镜下逆行胰胆管造影术后胆道出血的因素分析与护理措施[J]. 血栓与止血学, 2022, 28( 1): 131－ 133.
[18]	TAN ZG, FENG SK, WANG J, et al. Risk of biliary bleeding after therapeutic endoscopic retrograde cholangiopancreatography in different primary diseases and its prevention and treatment[J]. Chin Foreign Med Res, 2020, 18( 1): 134－ 136. DOI: 10.14033/j.cnki.cfmr.2020.01.058. 谭增光, 冯树开, 王军, 等. 不同原发疾病行治疗性经内镜逆行胰胆管造影术后胆道出血的风险及防治对策[J]. 中外医学研究, 2020, 18( 1): 134－ 136. DOI: 10.14033/j.cnki.cfmr.2020.01.058.
[19]	LIANG Y, ZHONG WZ, LIN C, et al. Analysis of risk factors and preventive measures of post－ERCP secondary hemorrhage in patients with choledocholithiasis[J]. J Hunan Norm Univ Med Sci, 2020, 17( 3): 156－ 159. DOI: 10.3969/j.issn.1673－016X.2020.03.047. 梁毅, 钟文洲, 林诚, 等. 经内镜逆行胰胆管造影胆总管取石术后继发出血的危险因素和处理对策分析[J]. 湖南师范大学学报(医学版), 2020, 17( 3): 156－ 159. DOI: 10.3969/j.issn.1673－016X.2020.03.047.
[20]	MA ZJ, WANG XZ, XU X, et al. Influencing factors of postoperative delayed bleeding in patients with choledocholithiasis undergoing endoscopic retrograde cholangiopancreatography[J]. Guangxi Med J, 2019, 41( 8): 974－ 977. DOI: 10.11675/j.issn.0253－4304.2019.08.11. 马镇坚, 王小忠, 许选, 等. 胆总管结石患者行内镜下逆行胰胆管造影术后发生迟发性出血的影响因素分析[J]. 广西医学, 2019, 41( 8): 974－ 977. DOI: 10.11675/j.issn.0253－4304.2019.08.11.
[21]	CAI ZF, GU J, ZHAO P. Risk factors of duodenal papilla hemorrhage after ERCP for choledocholithiasis[J]. China J Endosc, 2018, 24( 7): 14－ 19. DOI: 10.3969/j.issn.1007－1989.2018.07.003. 蔡治方, 顾进, 赵鹏. 胆总管结石内镜逆行胰胆管造影术后并发十二指肠乳头出血的危险因素分析[J]. 中国内镜杂志, 2018, 24( 7): 14－ 19. DOI: 10.3969/j.issn.1007－1989.2018.07.003.
[22]	WANG QR, ZHANG Y, MOU D, et al. Association between hematobilia and primary disease after therapeutic endoscopic retrograde cholangiopancreatography[J]. J Clin Hepatol, 2017, 33( 5): 896－ 898. DOI: 10.3969/j.issn.1001－5256.2017.05.021. 王群茹, 张勇, 牟东, 等. 治疗性经内镜逆行胰胆管造影术后胆道出血与原发疾病的关系[J]. 临床肝胆病杂志, 2017, 33( 5): 896－ 898. DOI: 10.3969/j.issn.1001－5256.2017.05.021.
[23]	WU XP. Clinical characteristics and risk factors of biliary bleeding after endoscopic retrograde cholangiopancreatography[J]. Mod Pract Med, 2021, 33( 5): 683－ 685. DOI: 10.3969/j.issn.1671－0800.2021.05.063. 吴晓平. 经内镜逆行胰胆管造影术后胆道出血的临床特征及高危因素分析[J]. 现代实用医学, 2021, 33( 5): 683－ 685. DOI: 10.3969/j.issn.1671－0800.2021.05.063.
[24]	GUO M, LI N, WU JG, et al. Risk factors and treatment measures of delayed bleeding after ERCP[J]. Zhejiang Pract Med, 2021, 26( 2): 127－ 129, 136. DOI: 10.16794/j.cnki.cn33－1207/r.2021.02.010. 郭明, 李宁, 吴加国, 等. ERCP术后迟发性出血的危险因素及治疗措施[J]. 浙江实用医学, 2021, 26( 2): 127－ 129, 136. DOI: 10.16794/j.cnki.cn33－1207/r.2021.02.010.
[25]	HUANG G, TIAN FY, AN W, et al. Effects of antithrombotic therapy on bleeding after endoscopic sphincterotomy: A systematic review and meta－analysis[J]. Endosc Int Open, 2022, 10( 6): E865－E873. DOI: 10.1055/a－1793－9479.
[26]	ZAKKO A, ZAKKO L, GRIMSHAW AA, et al. Antiplatelet monotherapy is associated with an increased risk of bleeding after endoscopic sphincterotomy[J]. Dig Dis Sci, 2022, 67( 8): 4161－ 4169. DOI: 10.1007/s10620－021－07302－w.
[27]	MASUDA S, KOIZUMI K, NISHINO T, et al. Direct oral anticoagulants increase bleeding risk after endoscopic sphincterotomy: A retrospective study[J]. BMC Gastroenterol, 2021, 21( 1): 401. DOI: 10.1186/s12876－021－01980－6.
[28]	BHURWAL A, MUTNEJA H, GOEL A, et al. No significant difference in post－ERCP bleeding rates between dual antiplatelet agents and aspirin alone: A systematic review and meta－analysis[J]. J Clin Gastroenterol, 2022, 56( 6): 546－ 551. DOI: 10.1097/MCG.0000000000001559.
[29]	KRILL T, LI DM, SOOD A, et al. Pharmacologic venous thromboembolism prophylaxis is not associated with post sphincterotomy bleeding after endoscopic retrograde cholangiopancreatography[J]. Dig Liver Dis, 2021, 53( 6): 766－ 771. DOI: 10.1016/j.dld.2021.03.033.
[30]	PARK JS, JEONG S, CHO JH, et al. Clinical outcome of endoscopic retrograde cholangiopancreatography for choledocholithiasis in end－stage renal disease patients on hemodialysis[J]. Turk J Gastroenterol, 2020, 31( 7): 538－ 546. DOI: 10.5152/tjg.2020.19521.
[31]	WENG H, WENG MZ, SHU YJ, et al. A prospective study on endoscopic papillary balloon dilatation and mechanical lithotripsy in treatment of choledocholithiasis: Dilatation or lithotripsy first[J]. J Surg Concepts Pract, 2022, 27( 3): 210－ 214. DOI: 10.16139/j.1007－9610.2022.03.006. 翁昊, 翁明哲, 束翌俊, 等. 乳头球囊扩张及机械碎石先后顺序对ERCP治疗胆总管结石影响的前瞻性研究[J]. 外科理论与实践, 2022, 27( 3): 210－ 214. DOI: 10.16139/j.1007－9610.2022.03.006.
[32]	WANG DL, LI J, XU L. Analysis of the effect of nipple balloon dilatation on pancreatitis and hemorrhage after ERCP[J]. China Health Stand Manag, 2020, 11( 23): 78－ 81. DOI: 10.3969/j.issn.1674－9316.2020.23.029. 王德良, 李俊, 许磊. 乳头球囊扩张对ERCP术后胰腺炎及出血的影响分析[J]. 中国卫生标准管理, 2020, 11( 23): 78－ 81. DOI: 10.3969/j.issn.1674－9316.2020.23.029.
[33]	FANG YT, SHEN HZ, JIN HB, et al. Risk factors of duodenal papilla hemorrhage after endoscopic papillary balloon dilatation for choledocholithiasis(with video)[J]. Chin J Dig Endosc, 2021, 38( 7): 560－ 564. DOI: 10.3760/cma.j.cn321463－20201106－00685. 方宇韬, 沈红璋, 金杭斌, 等. 内镜下乳头球囊扩张术治疗胆总管结石并发十二指肠乳头出血的危险因素分析(含视频)[J]. 中华消化内镜杂志, 2021, 38( 7): 560－ 564. DOI: 10.3760/cma.j.cn321463－20201106－00685.
[34]	WU JH, KANG JW, WANG YS, et al. Comparison of different endoscopic methods used for managing choledocholithiasis in patients with end－stage renal disease undergoing hemodialysis[J]. Dig Dis Sci, 2022, 67( 11): 5239－ 5247. DOI: 10.1007/s10620－021－07360－0.
[35]	ZHANG GF, SHI XT. Microanatomy of the carunculae major artery and its clinical significance[J]. Chin J Clin Anat, 2015, 33( 3): 262－ 264. DOI: 10.13418/j.issn.1001－165x.2015.03.006. 张国飞, 石小田. 十二指肠大乳头血供的临床解剖学研究[J]. 中国临床解剖学杂志, 2015, 33( 3): 262－ 264. DOI: 10.13418/j.issn.1001－165x.2015.03.006.
[36]	BAE SS, LEE DW, HAN JM, et al. Risk factor of bleeding after endoscopic sphincterotomy in average risk patients[J]. Surg Endosc, 2019, 33( 10): 3334－ 3340. DOI: 10.1007/s00464－018－06623－8.
[37]	ZONG W, LI YL, WAN BB, et al. Risk factors of post endoscopic retrograde cholangiopancreatography hemorrhage[J]. Shaanxi Med J, 2019, 48( 6): 774－ 777. DOI: 10.3969/j.issn.1000－7377.2019.06.025. 宗伟, 李玉龙, 万兵兵, 等. 内镜逆行胰胆管造影术后出血危险因素分析[J]. 陕西医学杂志, 2019, 48( 6): 774－ 777. DOI: 10.3969/j.issn.1000－7377.2019.06.025.
[38]	YAN J, ZHOU CX, WANG C, et al. Risk factors for delayed hemorrhage after endoscopic sphincterotomy[J]. Hepatobiliary Pancreat Dis Int, 2020, 19( 5): 467－ 472. DOI: 10.1016/j.hbpd.2019.12.010.
[39]	DUMONCEAU JM, ANDRIULLI A, et al. Prophylaxis of post－ERCP pancreatitis: European Society of Gastrointestinal Endoscopy(ESGE) guideline－updated June 2014[J]. Endoscopy, 2014, 46( 9): 799－ 815. DOI: 10.1055/s－0034－1377875.
[40]	TESTONI PA, MARIANI A, GIUSSANI A, et al. Risk factors for post－ERCP pancreatitis in high－ and low－volume centers and among expert and non－expert operators: A prospective multicenter study[J]. Am J Gastroenterol, 2010, 105( 8): 1753－ 1761. DOI: 10.1038/ajg.2010.136.
[41]	NAVANEETHAN U, KONJETI R, LOURDUSAMY V, et al. Precut sphincterotomy: Efficacy for ductal access and the risk of adverse events[J]. Gastrointest Endosc, 2015, 81( 4): 924－ 931. DOI: 10.1016/j.gie.2014.09.015.
[42]	CANENA J, LOPES L, FERNANDES J, et al. Efficacy and safety of primary, early and late needle－knife fistulotomy for biliary access[J]. Sci Rep, 2021, 11( 1): 16658. DOI: 10.1038/s41598－021－96142－9.
[43]	CHEN J, WAN JH, WU DY, et al. Assessing quality of precut sphincterotomy in patients with difficult biliary access: An updated meta－analysis of randomized controlled trials[J]. J Clin Gastroenterol, 2018, 52( 7): 573－ 578. DOI: 10.1097/MCG.0000000000001077.
[44]	TANG ZW, YANG Y, YANG ZF, et al. Early precut sphincterotomy does not increase the risk of adverse events for patients with difficult biliary access: A systematic review of randomized clinical trials with meta－analysis and trial sequential analysis[J]. Medicine, 2018, 97( 36): e12213. DOI: 10.1097/MD.0000000000012213.
[45]	LEE HJ, CHO CM, HEO J, et al. Impact of hospital volume and the experience of endoscopist on adverse events related to endoscopic retrograde cholangiopancreatography: A prospective observational study[J]. Gut Liver, 2020, 14( 2): 257－ 264. DOI: 10.5009/gnl18537.
[46]	VEITCH AM, RADAELLI F, ALIKHAN R, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology(BSG) and European Society of Gastrointestinal Endoscopy(ESGE) guideline update[J]. Endoscopy, 2021, 53( 9): 947－ 969. DOI: 10.1055/a－1547－2282.
[47]	ABRAHAM NS, BARKUN AN, SAUER BG, et al. American college of gastroenterology－Canadian association of gastroenterology clinical practice guideline: Management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period[J]. Am J Gastroenterol, 2022, 117( 4): 542－ 558. DOI: 10.14309/ajg.0000000000001627.
[48]	WEN N, WANG ZH, WU ZW, et al. Causes and prevention of delayed bleeding after ERCP and EST[J]. J Hepatopancreatobiliary Surg, 2020, 32( 1): 56－ 58. DOI: 10.11952/j.issn.1007－1954.2020.01.012. 温暖, 王正华, 吴志伟, 等. ERCP及EST术后迟发性出血的原因及防治[J]. 肝胆胰外科杂志, 2020, 32( 1): 56－ 58. DOI: 10.11952/j.issn.1007－1954.2020.01.012.
[49]	MANES G, PASPATIS G, AABAKKEN L, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy(ESGE) guideline[J]. Endoscopy, 2019, 51( 5): 472－ 491. DOI: 10.1055/a－0862－0346.
[50]	LI DF, YANG MF, CHANG X, et al. Endocut versus conventional blended electrosurgical current for endoscopic biliary sphincterotomy: A meta－analysis of complications[J]. Dig Dis Sci, 2019, 64( 8): 2088－ 2094. DOI: 10.1007/s10620－019－05513－w.
[51]	REY JF, BEILENHOFF U, NEUMANN CS, et al. European Society of Gastrointestinal Endoscopy(ESGE) guideline: The use of electrosurgical units[J]. Endoscopy, 2010, 42( 9): 764－ 772. DOI: 10.1055/s－0030－1255594.
[52]	de CLEMENTE JUNIOR CC, BERNARDO WM, FRANZINI TP, et al. Comparison between endoscopic sphincterotomy vs endoscopic sphincterotomy associated with balloon dilation for removal of bile duct stones: A systematic review and meta－analysis based on randomized controlled trials[J]. World J Gastrointest Endosc, 2018, 10( 8): 130－ 144. DOI: 10.4253/wjge.v10.i8.130.
[53]	LIU ZH, TAN YG, DING SH, et al. Preventive effect of delayed bleeding after ERCP with preventive titanium clamp[J]. Shenzhen J Integr Tradit Chin West Med, 2020, 30( 13): 92－ 94, 199. DOI: 10.16458/j.cnki.1007－0893.2020.13.046. 刘朝晖, 谭永港, 丁世华, 等. 预防性钛夹夹闭对ERCP术后迟发性出血的预防效果[J]. 深圳中西医结合杂志, 2020, 30( 13): 92－ 94, 199. DOI: 10.16458/j.cnki.1007－0893.2020.13.046.
[54]	LI F, JI JM, GONG B, et al. Clinical effect of hemostasis clip on prevention of delayed bleeding after endoscopic retrograde cholangiopancreatography in patients with high risk of bleeding[J]. J Hepatopancreatobiliary Surg, 2020, 32( 6): 341－ 345, 384. DOI: 10.11952/j.issn.1007－1954.2020.06.005. 李甫, 吉建梅, 龚彪, 等. 止血夹预防高危出血患者ERCP术后迟发性出血的临床效果[J]. 肝胆胰外科杂志, 2020, 32( 6): 341－ 345, 384. DOI: 10.11952/j.issn.1007－1954.2020.06.005.
[55]	LEUNG WK, BUT DY, WONG SY, et al. Prevention of post－sphincterotomy bleeding by proton pump inhibitor: A randomized controlled trial[J]. J Dig Dis, 2018, 19( 6): 369－ 376. DOI: 10.1111/1751－2980.12604.
[56]	YANG H, ZHOU M, REN HF, et al. Effects of somatostatin used at different time on prevention of gastrointestinal bleeding in elderly patients after ERCP and its effects on serum gastrointestinal hormone[J]. Geriatr Health Care, 2022, 28( 3): 632－ 635, 641. DOI: 10.3969/j.issn.1008－8296.2022.03.037. 杨宏, 周敏, 任宏飞, 等. 不同时期应用生长抑素预防老年患者ERCP术后消化道出血的效果及对血清胃肠激素指标的影响[J]. 老年医学与保健, 2022, 28( 3): 632－ 635, 641. DOI: 10.3969/j.issn.1008－8296.2022.03.037.
[57]	YANG J, ZHANG XW. Effect of application of somatostatin at different time points before and after ERCP on elderly patients with gastrointestinal bleeding[J]. Med Recapitul, 2021, 27( 1): 204－ 208. DOI: 10.3969/j.issn.1006－2084.2021.01.038. 杨娟, 张献文. ERCP术前与术后不同时机应用生长抑素对老年消化道出血患者的影响[J]. 医学综述, 2021, 27( 1): 204－ 208. DOI: 10.3969/j.issn.1006－2084.2021.01.038.
[58]	KATSINELOS P, LAZARAKI G, CHATZIMAVROUDIS G, et al. Impact of nitroglycerin and glucagon administration on selective common bile duct cannulation and prevention of post－ERCP pancreatitis[J]. Scand J Gastroenterol, 2017, 52( 1): 50－ 55. DOI: 10.1080/00365521.2016.1228117.
[59]	CARR－LOCKE DL, GREGG JA, AOKI TT. Effects of exogenous glucagon on pancreatic and biliary ductal and sphincteric pressures in man demonstrated by endoscopic manometry and correlation with plasma glucagon[J]. Digest Dis Sci, 1983, 28( 4): 312－ 320. DOI: 10.1007/BF01324947.
[60]	PERISETTI A, GOYAL H, SHARMA N. Clinical safety and outcomes of glucagon use during endoscopic retrograde cholangiopancreatography(ERCP)[J]. Endosc Int Open, 2022, 10( 4): E558－E561. DOI: 10.1055/a－1747－3242.
[61]	LIN WC, LIN HH, HUNG CY, et al. Clinical endoscopic management and outcome of post－endoscopic sphincterotomy bleeding[J]. PLoS One, 2017, 12( 5): e0177449. DOI: 10.1371/journal.pone.0177449.
[62]	ZHUANG W, GUO ZJ. Emergency endoscopic treatment of 10 cases of delayed bleeding after ERCP papillary incision and lithotomy[J]. Med J Chin People’s Armed Police Force, 2020, 31( 6): 533－ 534. DOI: 10.14010/j.cnki.wjyx.2020.06.022. 庄伟, 郭志娟. 急诊内镜下治疗ERCP乳头切开取石术后迟发性出血10例[J]. 武警医学, 2020, 31( 6): 533－ 534. DOI: 10.14010/j.cnki.wjyx.2020.06.022.
[63]	LEE MH, TSOU YK, LIN CH, et al. Predictors of re－bleeding after endoscopic hemostasis for delayed post－endoscopic sphincterotomy bleeding[J]. World J Gastroenterol, 2016, 22( 11): 3196－ 3201. DOI: 10.3748/wjg.v22.i11.3196.
[64]	SHAH JN, MARSON F, BINMOELLER KF. Temporary self－expandable metal stent placement for treatment of post－sphincterotomy bleeding[J]. Gastrointest Endosc, 2010, 72( 6): 1274－ 1278. DOI: 10.1016/j.gie.2010.08.012.
[65]	CONTHE A, NOGALES Ó, MARTÍNEZ FLORES C, et al. Usefulness of fully covered self－expandable biliary metal stents for the treatment of post－sphyncterotomy ERCP bleeding[J]. Rev Esp Enferm Dig, 2019, 111( 12): 931－ 934. DOI: 10.17235/reed.2019.6393/2019.
[66]	INOUE T, IBUSUKI M, KITANO R, et al. Early covered self－expandable metal stent placement is effective for massive post－endoscopic sphincterotomy bleeding[J]. Dig Dis Sci, 2020, 65( 11): 3324－ 3331. DOI: 10.1007/s10620－020－06057－0.
[67]	GUZMÁN－CALDERÓN E, RUIZ F, CASELLAS JA, et al. Endoscopic ultrasound－guided injection of coils for the treatment of refractory post－ERCP bleeding[J]. Endoscopy, 2020, 52( 8): 702－ 703. DOI: 10.1055/a－1103－1806.
[68]	ORLANDINI B, SCHEPIS T, TRINGALI A, et al. Fibrin glue injection: Rescue treatment for refractory post－sphincterotomy and post－papillectomy bleedings[J]. Dig Endosc, 2021, 33( 5): 815－ 821. DOI: 10.1111/den.13857.
[69]	INOUE T, IBUSUKI M, KITANO R, et al. Usefulness of red dichromatic imaging for post－endoscopic sphincterotomy bleeding[J]. Endoscopy, 2022, 54(S 02): E778－E 779. DOI: 10.1055/a－1806－1605.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (343) PDF downloads(34)

Research advances in hemorrhage after endoscopic retrograde cholangiopancreatography

DOI: 10.3969/j.issn.1001-5256.2023.10.032

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Research advances in hemorrhage after endoscopic retrograde cholangiopancreatography

DOI: 10.3969/j.issn.1001-5256.2023.10.032

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content